common glp-1 agonists Are Serious Anesthesia Risks of Semaglutide and Other Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia Benefits and Risks of GLP-1
Description
This study aims to comprehensively review the impact of GLP-1 RAs on various body systems, emphasizing both positive and negative effects while addressing existing knowledge gaps in the literature
People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, according to a new study.
The clinical data is real
Indication expansion, such as approvals for additional metabolic and cardiovascular conditions, is broadening patient access and driving adoption
However, the molecular details of ago-allosterism remain elusive
Lets explore each type of medication in more detail.
